- Title
- Recombinant Zoster Vaccine [RZV] is Effective in Patients with Inflammatory Bowel Disease: A US Propensity Matched Cohort Study
- Creators
- Aakash Desai (Corresponding Author) - Mayo Clinic in FloridaJana G. Hashash - Mayo Clinic in FloridaGursimran S. Kochhar - Allegheny Health NetworkMary S. Hayney - University of Wisconsin–MadisonFreddy Caldera - University of Wisconsin–MadisonFrancis A. Farraye - Mayo Clinic in Florida
- Publication Details
- Journal of Crohn's and colitis, v 18(6), pp 828-835
- Publisher
- Oxford University Press
- Number of pages
- 8
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- General Internal Medicine
- Web of Science ID
- WOS:001168146600001
- Scopus ID
- 2-s2.0-85191754365
- Other Identifier
- 991022135626204721
Journal article
Recombinant Zoster Vaccine [RZV] is Effective in Patients with Inflammatory Bowel Disease: A US Propensity Matched Cohort Study
Journal of Crohn's and colitis, v 18(6), pp 828-835
03 Jun 2024
PMID: 38224526
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Metrics
2 Record Views
Details
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Gastroenterology & Hepatology